HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.

CARDIOLOGY CLINICS is a prestigious journal published by W B SAUNDERS CO-ELSEVIER INC, offering insightful and comprehensive reviews in the field of cardiology and cardiovascular medicine since its inception in 1983. With its ISSN 0733-8651 and E-ISSN 1558-2264, the journal has established a significant impact factor within the academic community, holding a Q2 ranking in both Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous) for 2023. Located in the heart of Philadelphia, USA, it serves as a vital resource for researchers, clinicians, and students seeking to deepen their understanding of cardiovascular diseases and advancements in treatment. Although it operates under a traditional subscription model, the journal remains committed to disseminating valuable knowledge that shapes current practices and informs future research directions. As it converges towards its 2024 issues, CARDIOLOGY CLINICS continues to play an influential role in enhancing the discourse on cardiovascular health worldwide, ensuring that its audience stays at the forefront of clinical and scientific developments.

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

Circulation-Arrhythmia and Electrophysiology, published by Lippincott Williams & Wilkins, is a premier journal dedicated to advancing the field of cardiology and electrophysiology. With a strong emphasis on clinical and experimental research, this journal serves as a critical platform for disseminating innovative findings concerning arrhythmias and cardiac electrical activity. Operating in a highly competitive academic environment, it boasts an impressive Q1 ranking in key categories such as Cardiology and Cardiovascular Medicine, as well as Physiology (medical), positioning it within the top tier of publications in these fields. Spanning a comprehensive converged period from 2008 to 2024, Circulation-Arrhythmia and Electrophysiology offers researchers and clinicians access to cutting-edge studies that inform best practices and influence treatment protocols. Although it does not provide open access options, it remains invaluable for professionals seeking to enhance their understanding of complex electrophysiological phenomena and contribute to the evolution of cardiovascular care.

HEART RHYTHM is a leading academic journal published by Elsevier Science Inc, focusing on cutting-edge research in the field of cardiology and cardiovascular medicine. Established in 2004 and continuing its impactful journey through 2024, this journal holds an esteemed position within the academic community, boasting a 2023 Q1 ranking in both Cardiology and Cardiovascular Medicine and Medical Physiology, indicating its significant influence and contribution to these areas of study. With a commendable Scopus ranking—ranked #34 out of 387 in Cardiology and #11 out of 113 in Physiology—HEART RHYTHM is recognized for publishing high-quality research that drives advancements in understanding heart rhythms and associated medical conditions. Although it does not support open access, the journal remains accessible to professionals, researchers, and students, serving as a vital resource for the latest findings and theories in cardiovascular health. Invested in the mission to enhance knowledge and improve clinical practices, HEART RHYTHM stands as an essential publication for those aspiring to excel in the fields of cardiology and cardiovascular research.

The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.

Annals of Cardiac Anaesthesia is a distinguished open-access journal published by Wolters Kluwer Medknow Publications since 2008, focusing on the interplay between anaesthesia practices and cardiovascular health. With an ISSN of 0971-9784 and an E-ISSN of 0974-5181, this journal serves as a vital resource for researchers, practitioners, and students in the fields of Anesthesiology, Cardiology, and Medicine. Operating in India and contributing significantly to the global medical community, it ranks in the Q3 category for both Anesthesiology and Pain Medicine, as well as Cardiology and Cardiovascular Medicine, reflecting its growing impact within these domains. The journal encompasses a wide array of topics, from surgical anaesthesia techniques to cardiovascular physiology, aiming to enhance clinical practice and outcomes. With Scopus rankings placing it at 75th in Anesthesiology and 267th in Cardiology, Annals of Cardiac Anaesthesia strives to foster knowledge exchange and innovation, making it an essential platform for those committed to advancing cardiac anaesthesia science.

Annals of Pediatric Cardiology is a distinguished peer-reviewed journal published by Wolters Kluwer Medknow Publications, focusing on the critical intersection of cardiology and pediatric health. Since its inception in 2008 as an Open Access journal, it has been at the forefront of disseminating significant research findings, clinical practices, and advancements in the field of pediatric cardiology. With an ISSN of 0974-2069 and an E-ISSN of 0974-5149, this journal is crucial for researchers, clinicians, and students seeking to enhance their knowledge in cardiological care for children. The journal's impact is underscored by its presence in the Q3 quartile in both Cardiology and Cardiovascular Medicine and Pediatrics, Perinatology, and Child Health categories for 2023, demonstrating its relevance in contemporary medical research. Operating out of India, the journal addresses a gap in pediatric cardiology literature, offering a platform for high-quality research and case studies that inform clinical practice and policy.

Expert Review of Cardiovascular Therapy is a leading academic journal published by TAYLOR & FRANCIS INC, focusing on innovative and impactful research in the field of cardiovascular medicine. With an ISSN of 1477-9072 and an E-ISSN of 1744-8344, this journal serves as an essential resource for researchers, clinicians, and educators, offering a platform for the dissemination of critical advancements in cardiovascular therapy and internal medicine. Since its inception in 2003, the journal has maintained a reputable standing with a Q2 ranking in various categories including Cardiology and Cardiovascular Medicine, reflecting its influence and rigor in the field. The journal, which is based in the United Kingdom, does not currently offer Open Access options, ensuring that its content is accessible primarily to subscribers. With its commitment to high-quality, peer-reviewed articles, Expert Review of Cardiovascular Therapy is dedicated to bridging the gap between experimental research and clinical application, thereby enhancing patient care and therapeutic outcomes in cardiovascular health.

Cardiogenetics, published by MDPI, is a leading open-access journal dedicated to advancing the field of genetics as it pertains to cardiovascular health and diseases. Since its launch in 2011, this journal has been at the forefront of disseminating high-quality research that explores the genetic underpinnings of cardiovascular conditions, offering a platform for innovative studies, reviews, and case reports. With an ISSN of 2035-8253 and an E-ISSN of 2035-8148, Cardiogenetics aims to bridge the gap between genetic research and clinical application, helping researchers, healthcare professionals, and students stay abreast of the latest advancements and findings. The journal’s commitment to open access ensures that its valuable content is available to a global audience, fostering greater collaboration and knowledge sharing in the cardiovascular genetics community. By contributing to this dynamic field, Cardiogenetics plays a crucial role in improving patient outcomes and paving the way for personalized medicine in cardiology.